Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follicular Stem Cells for Alopecia
NCT05210452Phase 2Unknown
- Start
- Mar 2022
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
01
Overview
Phase 2, open-label trial of autologous follicular stem cells in alopecia (2 arms). Primary endpoint: Number of cured patients at 6 months. Status: unknown.
02
Drugs
autologous follicular stem cells
03
Conditions
alopecia
Beyond the preview
Go deeper on NCT05210452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05210452.